Importer of Controlled Substances Application: Sigma Aldrich Co., LLC, 31620-31621 [2019-14025]
Download as PDF
<![CDATA[
khammond on DSKBBV9HB2PROD with NOTICES
31620
Federal Register / Vol. 84, No. 127 / Tuesday, July 2, 2019 / Notices
1, 2–6, 8, 10, 19, 20–28, 29, and 30–33
of the ’923 patent; claims 1, 2–3, 11, 12–
14, 17, 19, 20, 21–23, 26 and 28 of the
’206 patent; claims 1, 2–7, 8, 9–13, 14,
and 15–20 of the ’199 patent; and claims
9, 10–19, and 20 of the ’783 patent, and
whether an industry in the United
States exists as required by subsection
(a)(2) of section 337;
(2) Pursuant to section 210.10(b)(1) of
the Commission’s Rules of Practice and
Procedure, 19 CFR 210.10(b)(1), the
plain language description of the
accused products or category of accused
products, which defines the scope of the
investigation, is ‘‘barcode scanners,
barcode readers, barcode decoders,
stationary scanners, handheld scanners,
companion scanners, cabled scanners,
wireless scanners, mobile scanning
devices, handheld computers, and/or
scan engines’’;
(3) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainants are:
Honeywell International, Inc., 115 Tabor
Road, Morris Plains, NJ 07950
Hand Held Products, Inc., 9680 Old
Bailes Road, Fort Mill, SC 29707
Metrologic Instruments, Inc., 9680 Old
Bailes Road, Fort Mill, SC 29707
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the amended complaint is to be
served:
Opticon, Inc., 2200 Lind Ave. SW, Suite
100, Renton, WA 98057
Opticon Sensors Europe B.V., Opaallaan
35, 2132 XV Hoofddorp, The
Netherlands
OPTO Electronics Co., Ltd., 12–17,
Tsukagoshi 4-chome, Warabi-city
Saitama Pref., 335–0002, Japan
Hokkaido Electronic Industry Co., Ltd.,
118–122 Kamiashibetsu-cho,
Ashibetsu-shi, Hokkaido, 079–1371,
Japan
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
The Office of Unfair Import
Investigations will not be named as a
party to this investigation.
Responses to the complaint and the
notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), such
responses will be considered by the
Commission if received not later than 20
VerDate Sep<11>2014
17:00 Jul 01, 2019
Jkt 247001
days after the date of service by the
Commission of the complaint and the
notice of investigation. Extensions of
time for submitting responses to the
complaint and the notice of
investigation will not be granted unless
good cause therefor is shown.
Failure of a respondent to file a timely
response to each allegation in the
complaint and in this notice may be
deemed to constitute a waiver of the
right to appear and contest the
allegations of the complaint and this
notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the complaint and this notice
and to enter an initial determination
and a final determination containing
such findings, and may result in the
issuance of an exclusion order or a cease
and desist order or both directed against
the respondent.
By order of the Commission.
Issued: June 27, 2019.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2019–14077 Filed 7–1–19; 8:45 am]
BILLING CODE 7020–02–P
By order of the Commission.
Issued: June 26, 2019.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2019–14170 Filed 6–28–19; 11:15 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Absolute
Standards, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 3, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
DATES:
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 22, 2019, Absolute
Standards, Inc., 44 Rossotto Drive,
Hamden, Connecticut 06514–1335
applied to be registered as a bulk
manufacturer of the following basic
class of controlled substance:
SUPPLEMENTARY INFORMATION:
INTERNATIONAL TRADE
COMMISSION
[USITC SE–19–025]
Sunshine Act Meetings
United
States International Trade Commission.
TIME AND DATE: July 10, 2019 at 11:00
a.m.
PLACE: Room 101, 500 E Street SW,
Washington, DC 20436, Telephone:
(202) 205–2000.
STATUS: Open to the public.
MATTERS TO BE CONSIDERED:
1. Agendas for future meetings: None.
2. Minutes.
3. Ratification List.
4. Vote on Inv. Nos. 701–TA–453 and
731–TA–1136–1137 (Second
Review) (Sodium Nitrite from China
and Germany). The Commission is
currently scheduled to complete
and file its determinations and
views of the Commission by July
31, 2019.
5. Outstanding action jackets: None.
The Commission is holding the
meeting under the Government in the
Sunshine Act, 5 U.S.C. 552(b). In
accordance with Commission policy,
subject matter listed above, not disposed
of at the scheduled meeting, may be
carried over to the agenda of the
following meeting.
AGENCY HOLDING THE MEETING:
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Controlled
substance
Drug code
Pentobarbital ....
2270
Schedule
II
The company plans to bulk
manufacture the listed controlled
substance for distribution to customers.
Dated: June 19, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019–14029 Filed 7–1–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Sigma Aldrich Co., LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
DATES:
E:\FR\FM\02JYN1.SGM
02JYN1
31621
Federal Register / Vol. 84, No. 127 / Tuesday, July 2, 2019 / Notices
comments on or objections to the
issuance of the proposed registration on
or before August 1, 2019. Such persons
may also file a written request for a
hearing on the application on or before
August 1, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR
1301.34(a), this is notice that on
February 18, 2019, Sigma Aldrich Co.,
LLC, 3500 DeKalb Street, Saint Louis,
Missouri 63118 applied to be registered
as an importer of the following basic
classes of controlled substances:
Controlled substance
Drug code
khammond on DSKBBV9HB2PROD with NOTICES
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ....................................................................................................................
Aminorex ..........................................................................................................................................................................
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Methaqualone ..................................................................................................................................................................
Alpha-ethyltryptamine ......................................................................................................................................................
Ibogaine ...........................................................................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Mescaline .........................................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .............................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..........................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .............................................................................................................................
2,5-Dimethoxyamphetamine ............................................................................................................................................
3,4-Methylenedioxyamphetamine ....................................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine .......................................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
4-Methoxyamphetamine ..................................................................................................................................................
Bufotenine ........................................................................................................................................................................
Diethyltryptamine .............................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
Psilocyn ...........................................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ...............................................................................................................................
N-Benzylpiperazine ..........................................................................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .......................................................................................................................
Heroin ..............................................................................................................................................................................
Normorphine ....................................................................................................................................................................
Etonitazene ......................................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Glutethimide .....................................................................................................................................................................
Nabilone ...........................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Ethylmorphine ..................................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Opium, powdered ............................................................................................................................................................
Levo-alphacetylmethadol .................................................................................................................................................
The company plans to import the
listed controlled substances for sale to
research facilities for drug testing and
analysis. In reference to drug codes 7360
and 7370 the company plans to import
a synthetic cannabidiol and a synthetic
tetrahydrocannabinol. No other
activities for these drug codes are
authorized for this registration.
1235
1237
1248
1585
2010
2565
7249
7260
7315
7360
7370
7381
7391
7392
7395
7396
7400
7402
7404
7405
7411
7433
7434
7435
7438
7470
7493
7535
9200
9313
9624
2125
2315
2550
7379
7471
9170
9180
9190
9220
9230
9333
9639
9648
Dated: June 18, 2019.
John J. Martin,
Assistant Administrator.
DEPARTMENT OF JUSTICE
[FR Doc. 2019–14025 Filed 7–1–19; 8:45 am]
[Docket No. DEA–392]
BILLING CODE 4410–09–P
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
Drug Enforcement Administration
Importer of Controlled Substances
Registration
ACTION:
Notice of registration.
The registrant listed below
has applied for and been granted
registration by the Drug Enforcement
SUMMARY:
VerDate Sep<11>2014
17:00 Jul 01, 2019
Jkt 247001
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
E:\FR\FM\02JYN1.SGM
02JYN1
]]>Agencies
[Federal Register Volume 84, Number 127 (Tuesday, July 2, 2019)]
[Notices]
[Pages 31620-31621]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-14025]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Sigma Aldrich Co.,
LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written
[[Page 31621]]
comments on or objections to the issuance of the proposed registration
on or before August 1, 2019. Such persons may also file a written
request for a hearing on the application on or before August 1, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on
February 18, 2019, Sigma Aldrich Co., LLC, 3500 DeKalb Street, Saint
Louis, Missouri 63118 applied to be registered as an importer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Cathinone.......................... 1235 I
Methcathinone...................... 1237 I
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
Aminorex........................... 1585 I
Gamma Hydroxybutyric Acid.......... 2010 I
Methaqualone....................... 2565 I
Alpha-ethyltryptamine.............. 7249 I
Ibogaine........................... 7260 I
Lysergic acid diethylamide......... 7315 I
Marihuana.......................... 7360 I
Tetrahydrocannabinols.............. 7370 I
Mescaline.......................... 7381 I
4-Bromo-2,5-dimethoxyamphetamine... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine 7392 I
4-Methyl-2,5-dimethoxyamphetamine.. 7395 I
2,5-Dimethoxyamphetamine........... 7396 I
3,4-Methylenedioxyamphetamine...... 7400 I
N-Hydroxy-3,4- 7402 I
methylenedioxyamphetamine.
3,4-Methylenedioxy-N- 7404 I
ethylamphetamine.
3,4-Methylenedioxymethamphetamine.. 7405 I
4-Methoxyamphetamine............... 7411 I
Bufotenine......................... 7433 I
Diethyltryptamine.................. 7434 I
Dimethyltryptamine................. 7435 I
Psilocyn........................... 7438 I
1-[1-(2- 7470 I
Thienyl)cyclohexyl]piperidine.
N-Benzylpiperazine................. 7493 I
MDPV (3,4- 7535 I
Methylenedioxypyrovalerone).
Heroin............................. 9200 I
Normorphine........................ 9313 I
Etonitazene........................ 9624 I
Amobarbital........................ 2125 II
Secobarbital....................... 2315 II
Glutethimide....................... 2550 II
Nabilone........................... 7379 II
Phencyclidine...................... 7471 II
Diphenoxylate...................... 9170 II
Ecgonine........................... 9180 II
Ethylmorphine...................... 9190 II
Levorphanol........................ 9220 II
Meperidine......................... 9230 II
Thebaine........................... 9333 II
Opium, powdered.................... 9639 II
Levo-alphacetylmethadol............ 9648 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances for
sale to research facilities for drug testing and analysis. In reference
to drug codes 7360 and 7370 the company plans to import a synthetic
cannabidiol and a synthetic tetrahydrocannabinol. No other activities
for these drug codes are authorized for this registration.
Dated: June 18, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-14025 Filed 7-1-19; 8:45 am]
BILLING CODE 4410-09-P
